|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 47/68 | (2017.01) |
| C07H 15/203 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 3525830 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17791980.0 |
| Date of filing the European patent application | 2017-10-13 | |
| (97) | Date of publication of the European application | 2019-08-21 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-10 |
| (46) | Date of publication of the claims translation | 2021-06-25 |
| (86) | Number | PCT/EP2017/076162 |
| Date | 2017-10-13 |
| (87) | Number | WO 2018/069490 |
| Date | 2018-04-19 |
| (30) | Number | Date | Country code |
| 201617466 | 2016-10-14 | GB |
| (72) |
HOWARD, Philip Wilson, GB
GREGSON, Stephen John, GB
|
| (73) |
Medimmune Limited,
Milstein Building Granta Park, Cambridge, Cambridgeshire CB21 6GH,
GB
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Pirolbenzodiazepino konjugatai |
| PYRROLOBENZODIAZEPINE CONJUGATES |
| Payment date | Validity (years) | Amount | |
| 2025-01-24 | 8 | 277.50 EUR |
| 2025-10-13 |